**7. Conclusive remarks**

In conclusion, the answers to the question when and why the liquid biopsy is useful in glioblastoma disease, could be different in function of the phase of disease:


in which therapeutic drugs may be favorite to cross BBB. Moreover, those patients in which the BBB opening is not detectable through liquid biopsy could be considered a different therapeutic approach using EVs.
